The oncogene SS18-SSX1 facilitates tumourigenesis by increasing the expression of SHCBP1 and lowering the PI3K/AKT/mTOR and MAPK/ERK signalling pathways and cyclin D1 expression; hence, SS18-SSX1 generally acts as a tumour promoter 18. This evidence concerns the gene AKT1 and neoplasm.